You are here
Visiongain Report Provides Critical Market-led Data on the $11.7bn Asia Vaccines Market
Asia Vaccines Market Forecast to 2029
Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV
LONDON, Nov. 26, 2019 /PRNewswire/ -- Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during the first half of the forecast period. The Japanese vaccines market held 30% share of the Asian vaccines market in 2018.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 178-page report you will receive 82 charts– all unavailable elsewhere.
The 178-page Visiongain report provides clear detailed insight into the Asian vaccines market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
To request sample pages from this report please contact Sara Peerun at firstname.lastname@example.org or refer to our website: https://www.visiongain.com/report/asia-vaccines-market-forecast-to-2029/#download_sampe_div
• Asia Vaccines Market revenue forecasts to 2029
• Asia Vaccines Market revenue forecasts to 2029 by Vaccine Technology:
• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Asia Vaccines Market revenue forecasts to 2029 by Indication:
• Asia Vaccines Market revenue forecasts to 2029 by Country:
• South Korea
• Rest of Asia
Further segmented by indication and vaccine technology.
• Profiles of the selected leading companies:
• CSL, Ltd.
• Emergent BioSolutions, Inc.
• Johnson & Johnson
• Mitsubishi Tanabe Pharma Corporation
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceuticals Industries, Ltd.
• This report provides a Pipeline Analysis
• This report discusses factors that drive and restrain the market. This report also discusses trends and opportunities in the market.
• Key Questions Answered by this Report:
• What is the current size of Asia vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape Asia vaccines market over the next ten years?
• What are the main segments within Asia vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the Asian vaccines market? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?
To request a report overview of this report please contact Sara Peerun at email@example.com or refer to our website: https://www.visiongain.com/report/asia-vaccines-market-forecast-to-2029/
Did you know that we also offer a report add-on service? Email firstname.lastname@example.org to discuss any customized research needs you may have.
Companies covered in the report include:
BIKEN Co. Ltd
Biological E. Limited
Biomedical Advanced Research and Development Authority (BARDA)
Cancer Research UK
Daiichi Sankyo Company, Ltd.
Emergent Biosolutions, Inc.
Ganymed Pharmaceuticals AG
Immunomic Therapeutics, Inc.
Johnson & Johnson
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Oswaldo Cruz Foundation
Potenza Therapeutics, Inc.
Serum Institute of India Pvt. Ltd.
Sun Pharmaceuticals Industries, Ltd.
University of Oxford
University of Tokyo
To see a report overview please e-mail Sara Peerun on email@example.com